WO2006129257A3 - Ketolide derivatives as antibacterial agents - Google Patents
Ketolide derivatives as antibacterial agents Download PDFInfo
- Publication number
- WO2006129257A3 WO2006129257A3 PCT/IB2006/051686 IB2006051686W WO2006129257A3 WO 2006129257 A3 WO2006129257 A3 WO 2006129257A3 IB 2006051686 W IB2006051686 W IB 2006051686W WO 2006129257 A3 WO2006129257 A3 WO 2006129257A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogen
- formula
- independently
- spp
- ketolide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
The present invention provides ketolide derivatives, which can be used as antibacterial agents. In particular, compounds described herein can be used for treating or preventing conditions caused by or contributed to by gram positive, gram negative or anaerobic bacteria, more particularly against, for example, Staphylococci, Streptococci, Enterococci, Haemophilus, Moraxalla spp., Chlamydia spp., Mycoplasm, Legionella spp., Mycobacterium, Helicobacter, Clostridium, Bacteroides, Corynebacterium, Bacillus or Enterobactericeae. Also provided are processes for preparing such ketolide. derivatives, pharmaceutical compositions thereof, and methods of treating bacterial infections. The compounds have the following structure, Formula (I), wherein R can be Formula (II), (wherein Zi can be hydrogen or melhyl, Z2 can be hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy, amino, nitro, cyano or amido, Z3 can be hydrogen, fluorine, chlorine, bromine or iodine, X1 can be CR4, CR4 R’4N, NR4, O or S, X2 can be CR4 or N wherein R4 and R'4 independently in each occurrence can be hydrogen or C1-3 alky, R2 and R3 can be independently Formula (III), wherein, X3-X13 can be independenËy C(R4 ) 0-2, N(R4)0-1, O or S, R5-R10 can be independently hydrogen, halogen, C1-3 alkyl, C1-3 alkoxy, amino, nilro, cyano, aryl or heteroaryl), Y is hydrogen or methyl, and is an optional single bond.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1383DE2005 | 2005-05-30 | ||
IN1383/DEL/2005 | 2005-05-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006129257A2 WO2006129257A2 (en) | 2006-12-07 |
WO2006129257A3 true WO2006129257A3 (en) | 2007-02-08 |
Family
ID=36954773
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2006/051686 WO2006129257A2 (en) | 2005-05-30 | 2006-05-26 | Ketolide derivatives as antibacterial agents |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2006129257A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009053259A1 (en) * | 2007-10-25 | 2009-04-30 | Sandoz Ag | Process for the production of telithromycin |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
US5635485A (en) * | 1994-05-03 | 1997-06-03 | Roussel Uclaf | Erythromycin compounds |
WO1999016779A1 (en) * | 1997-09-30 | 1999-04-08 | Abbott Laboratories | 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity |
WO2003004509A2 (en) * | 2001-07-03 | 2003-01-16 | Chiron Corporation | C12 modified erythromycin macrolides and ketolides having antibacterial activity |
-
2006
- 2006-05-26 WO PCT/IB2006/051686 patent/WO2006129257A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5527780A (en) * | 1992-11-05 | 1996-06-18 | Roussel Uclaf | Erythromycin derivatives |
US5635485A (en) * | 1994-05-03 | 1997-06-03 | Roussel Uclaf | Erythromycin compounds |
WO1999016779A1 (en) * | 1997-09-30 | 1999-04-08 | Abbott Laboratories | 3'-n-modified 6-o-substituted erythromycin ketolide derivatives having antibacterial activity |
WO2003004509A2 (en) * | 2001-07-03 | 2003-01-16 | Chiron Corporation | C12 modified erythromycin macrolides and ketolides having antibacterial activity |
Non-Patent Citations (2)
Title |
---|
DENIS, ALEXIS ET AL: "Novel fluoroketolides: Synthesis and antibacterial activity", DRUGS OF THE FUTURE , 26(10), 975-984 CODEN: DRFUD4; ISSN: 0377-8282, 2001, XP002399583 * |
DENIS, ALEXIS ET AL: "Synthesis and antibacterial activity of HMR 3647, a new ketolide highly potent against erythromycin-resistant and susceptible pathogens", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS , 9(21), 3075-3080 CODEN: BMCLE8; ISSN: 0960-894X, 1999, XP004181010 * |
Also Published As
Publication number | Publication date |
---|---|
WO2006129257A2 (en) | 2006-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Hooper | Mode of action of fluoroquinolones | |
BRPI0513903A (en) | ketolide derivatives useful as antimicrobial agents, their preparation processes and pharmaceutical compositions comprising the same | |
WO2007044724A3 (en) | Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3 | |
IL165715A (en) | 2-ureido-6-heteroaryl-3h-benzimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
WO2007085451A3 (en) | 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents | |
HUP0303756A2 (en) | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands and process for their preparation and pharmaceutical compositions containing them | |
WO2007060518A3 (en) | Ketolide derivatives as antibacterial agents | |
MY147369A (en) | (1-aza-bicyclo[3.3.1]non-4-yl)-5-(1h-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-achr for the treatment of psychotic and neurodegenerative disoders | |
AU2001245972A1 (en) | N-heterocyclic derivatives as nos inhibitors | |
MX2009007482A (en) | Antiparasitic agents. | |
NZ591051A (en) | C7-fluoro substituted tetracycline compounds | |
MXPA06003253A (en) | ((((1h-indol-3yl) methylidene)amino)oxy)acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of inpairement of the fibrinolytic system and of thrombosis. | |
NO20062533L (en) | 5-fluoro, 5-chloro and cyanopyridin-2-yl-tetrazoles as ligands for the metabotrophic glutamate receptor-5 | |
WO2010013222A8 (en) | Pyrrole carboxylic acid derivatives as antibacterial agents | |
TW200612920A (en) | Novel imidazolidine derivatives | |
EP1409464A4 (en) | Oxazolidinone derivatives as potential antimicrobials | |
WO2003072576A3 (en) | Oxazolidinone derivatives, processes for their preparation, and pharmaceutical compositions containing them | |
WO2008110690A3 (en) | Novel indole derivatives, methods for preparing same, and use thereof particularly as antibacterial agents | |
WO2006129257A3 (en) | Ketolide derivatives as antibacterial agents | |
MXPA05009688A (en) | Naphthyridine derivatives as antibacterial agents. | |
AU2002353768A1 (en) | 7-alkylidene-3-substituted-3-cephem-4-carboxylates as beta-lactamase inhibitors. | |
MX2010004442A (en) | Novel precursors. | |
WO2006046112A3 (en) | Ketolide derivatives as antibacterial agents | |
DE60125053D1 (en) | CEPHEM COMPOUNDS AND ESBL DETERGENT REAGENTS CONTAINING THEM | |
ATE445619T1 (en) | PYRIDINYLPYRAZOLOPYRIMIDINONE DERIVATIVES AS PDE 7 INHIBITORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
NENP | Non-entry into the national phase |
Ref country code: RU |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: RU |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06745033 Country of ref document: EP Kind code of ref document: A2 |